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Among adults (18 years and older), the use of
combustible tobacco products is the leading
preventable cause of mortality and results in a
wide range of morbidities.1 Nevertheless, social
normalization and nicotine dependence associated
with combustible tobacco use have made smoking
cessation a very difficult undertaking. Many
people who are well aware of the adverse effects of
combustible tobacco use continue to smoke, even
in the face of grave morbidity and death. There are
many FDA approved therapies for smoking cessation,
including nicotine replacement modalities and other
pharmaceutical drugs, yet many people are unable
to quit smoking using these therapies. It has been
estimated that most quit attempts (79%) last for less
than one day.2
Since their introduction into the US market in 2006,
electronic cigarettes, also known as e-cigarettes, have
been seen by many to be a powerful tool against
combustible tobacco use. The initial optimism that
surrounded e-cigarette use in the fight against
smoking has been tempered by controversies
surrounding its safety, efficacy, and the involvement
of tobacco companies in the production and
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marketing of e-cigarettes.3 This has essentially led to
a situation where this very potent tool has been left
to languish while the devastating health effects of
combustible tobacco use rages on. Many professional
healthcare societies do not have clear guidelines
for their healthcare providers when it comes to
e-cigarette use as a tool for smoking cessation or
prevention. Consequently, many healthcare providers
are uncertain about how to counsel their patient
about e-cigarettes.
So how did we get here? The e-cigarette was
invented by Hon Lik, a Chinese pharmacist, in 2003
to help himself quit smoking after his father died
from smoking.4 Consequently, the initial purpose of
e-cigarettes was to use them as a smoking cessation
tool, but its potential use as a smoking prevention
device has always been a consideration since its
invention. As a smoking cessation tool, e-cigarettes
have been shown by multiple studies to be effective
for smoking cessation.5 In one large trial, e-cigarettes
were more effective than nicotine patch, a first line
pharmacotherapeutic agent.6 In addition, users of
e-cigarettes appear to take a personal liking to these
devices, increasing compliance and making them
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unique in smoking cessation therapies by being
able to occupy the same psychological niche that
combustible cigarettes occupy.7 Obviously, in doing
so it does raise the question of replacing one evil with
another, but it has been demonstrated that although
e-cigarettes do produce harmful effects, including
shortness of breath, exacerbation of asthma,
potentially carcinogenic compounds resulting from
inhalation of e-liquid chemicals, malfunction of
delivery devices leading to injury to users and other
unknown long-term health consequences, these are
in no way near the magnitude of harm caused by the
use of combustible tobacco cigarettes.5
Conversely, e-cigarettes have not been shown to
be an effective smoking prevention tool. Mounting
evidence suggests that e-cigarette use, especially
among youths, may lead to subsequent increased
risk of using combustible tobacco products.8 This
may be partly because of aggressive marketing and
design of certain e-cigarette products, notably by the
e-cigarette manufacturer JUUL, towards the youth
such that they find it more appealing and easier
to use discretely owing to its flavored content and
compact physical form. Notwithstanding, one has
to keep in mind that by far the largest proportion
of e-cigarette users are current smokers or former
smokers and only a small fraction of individuals who
have never smoked cigarettes ever try e-cigarettes
(5.7%) or become chronic users of e-cigarettes
(0.7%).9 Therefore in reality, young people who do
not find smoking appealing in general, appear to be
unlikely to pick up the habit of e-cigarette smoking in
the first place.
Given the above premise, smoking cessation using
e-cigarettes with complete cessation of combustible
tobacco products should be recommended as a
smoking cessation tool for current smokers, who
have either failed to quit with the currently available
smoking cessation therapies or are unwilling to
try other therapies. This should be done with
the understanding that certain long-term health
consequences of e-cigarette use are currently
unknown but are significantly less harmful than
combustible cigarettes. This is clearly a difficult
needle to thread, but one which has great potential
to improve the health status of millions of individuals.
This is the challenge of e-cigarettes.
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